GLP-1 patient volume exhibited consistent and substantial growth throughout the observation period, with an initial 37.9% increase in 2019, ultimately reaching a 744.6% increase by 2023 relative to the 2018 baseline (Figure 1)
Study durations differ
Luo, H., Cheng, J., Han, J
Nevertheless, some drawbacks such as derivatization, cumbersome laboratory procedures, time consumption and applicable feasibility in vivo were not conducive to the development of a practical method
More common side effects of GLP-1 meds can include: Abdominal discomfort Constipation Diarrhea Dizziness Fatigue Headaches Nausea Vomiting Gut Check: 6 Tips & Tactics to Ease GLP-1 Side Effects Maybe youre taking a GLP-1 and are happy with your progress
FDA-approved age populations Another difference in FDA approval is age